Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans.

Authors

Renato V. Iozzo, Thomas Jefferson UniversityFollow
Liliana Schaefer, Universität Frankfurt Am Main HausFollow

Document Type

Article

Publication Date

10-1-2010

Comments

This article has been peer reviewed. It is the authors' final version prior to publication in FEBS Journal Volume 277, Issue 19, October 2010, Pages 3864-3875. The published version is available at DOI: 10.1111/j.1742-4658.2010.07797.x. Copyright © Blackwell Publishing

Abstract

The small leucine-rich proteoglycans (SLRPs) are involved in many aspects of mammalian biology, both in health and disease. They are now being recognized as key signaling molecules with an expanding repertoire of molecular interactions affecting not only growth factors, but also various receptors involved in controlling cell growth, morphogenesis and immunity. The complexity of SLRP signaling and the multitude of affected signaling pathways can be reconciled with a hierarchical affinity-based interaction of various SLRPs in a cell- and tissue-specific context. Here, we review this interacting network, describe new relationships of the SLRPs with tyrosine kinase and Toll-like receptors and critically assess their roles in cancer and innate immunity.

Recommended Citation

Iozzo, Renato V. and Schaefer, Liliana, "Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans." (2010). Department of Pathology, Anatomy, and Cell Biology Faculty Papers. Paper 56.
https://jdc.jefferson.edu/pacbfp/56

PubMed ID

20840584